Taken together, the classification of patients by ANCA specificity (PR3- vs. MPO-ANCA) provides practical diagnostic criteria better aligned to patient phenotype, outcomes, and treatment responses than does their classification by clinical diagnosis (GPA vs. MPA and EGPA) (for a review, see Reference [45]). This evidence concerns the gene MPO and eosinophilic granulomatosis with polyangiitis.